1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Morocco Pharmaceuticals and Healthcare Report Q3 2016

Morocco Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 96 pages

Includes 3 FREE quarterly updates

BMI View: The Moroccan government's increasing efforts to improve healthcare coverage will be thelargest driver of pharmaceutical growth in the country over the coming years. Morocco has seen recentimprovements towards its regulatory standards; however, the government's long-term commitment to thisarea remains questionable. Ongoing corruption issues and an unclear future regarding medicine prices inMorocco will result in the country maintaining its status as a challenging market for multinationaldrugmakers.Headline Expenditure Projections

- Pharmaceuticals: MAD13.39bn (USD1.37bn) in 2015 to MAD14.33bn (USD1.45bn) in 2016; +7.0% inlocal currency terms and +5.6% in US dollar terms. Forecast in line with last quarter.

- Healthcare: MAD56.71bn (USD5.82bn) in 2015 to MAD59.44bn (USD6.01bn) in 2016; +4.8% in localcurrency terms and +3.4% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Morocco Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Morocco 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 24
OTC Drug Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2014-2020) 29
Pharmaceuticals and Healthcare Risk/Reward Index 30
Middle East and Africa Risk/Reward Index - Q3 2016 30
Morocco Risk/ Reward Index 38
Rewards 38
Risks 39
Regulatory Review 41
Intellectual Property Issues 42
Pricing Regime 42
Reimbursement Regime 45
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Morocco 2010-2015) 52
Table: Healthcare Personnel (Morocco 2010-2015) 52
Table: Healthcare Activity (Morocco 2010-2015) 53
Healthcare Insurance 53
Research and Development 58
Clinical Trials 59
Epidemiology 59
Competitive Landscape 63
Research-Based Industry 63
Table: Members Of MIS, 2011 64
Table: Members Of AMIP, 2011 64
Generic Drugmakers 64
Table: Multinational Market Activity 67
Pharmaceutical Distribution 67
Pharmaceutical Retail Sector 68
Company Profile 70
GlaxoSmithKline 70
Laprophan 72
Pfizer 75
Sanofi 78
Sothema 82
Demographic Forecast 85
Demographic Outlook 85
Table: Population Headline Indicators (Morocco 1990-2025) 86
Table: Key Population Ratios (Morocco 1990-2025) 86
Table: Urban/Rural Population and Life Expectancy (Morocco 1990-2025) 87
Table: Population By Age Group (Morocco 1990-2025) 87
Table: Population By Age Group % (Morocco 1990-2025) 88
Glossary 90
Methodology 92
Pharmaceutical Expenditure Forecast Model 92
Healthcare Expenditure Forecast Model 92
Notes On Methodology 93
Risk/Reward Index Methodology 94
Index Overview 95
Table: Pharmaceutical Risk/Reward Index Indicators 95
Indicator Weightings 96

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.